About this trial
Developing a standardized methodology for the use of novel cryogenic catheters for transbronchial cryobiopsy and cryoablation of pulmonary lesions.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Patients undergoing lung transplant surgery
Disqualifiers
Organ donor ineligible to donate lungs
Healthy individuals
Trial design
Single group
Treatments tested in this trial
Cryo Ex Vivo
Diagnostic testLungs from patients undergoing lung transplantation after their removal from the recipient patient with previous informed consent signed before transplantation will be obtained. The organs will be placed in an acrylic box and will be kept at a temperature of 37 Celsius degrees. The lungs will be mechanically ventilated connected by an endotracheal tube size 8 inserted in the bronchus with the balloon inflated and a silk suture providing a hermetic closure proximal to the balloon. Tissue samples will be taken from the models and images will be performed.
Treatment groups
Trial outcomes
Primary outcomes
Measure of Pleural breakage (Absent or Present)
Develop a standardized methodology for the use of novel cryoprobes for transbronchial lung biopsies and ablation of pulmonary lesions
Temperature of ice ball at center; Temperature of ice ball at periphery; Temperature of ice ball at varying distances from ice ball
Develop a standardized methodology for the use of novel cryoprobes for transbronchial lung biopsies and ablation of pulmonary lesions
Model of cryogen
Develop a standardized methodology for the use of novel cryoprobes for transbronchial lung biopsies and ablation of pulmonary lesions
Freezing Time
Develop a standardized methodology for the use of novel cryoprobes for transbronchial lung biopsies and ablation of pulmonary lesions
Secondary outcomes
Blood loss and complication
Feasibility of transbronchial lung cryobiopsy and cryoablation
Sponsors and contacts
Click on the lead sponsor to view all of their trials.